Abstract
Significance: Proteins have shown promise as therapeutics and diagnostics, but their effectiveness is limited by our inability to spatially target their activity. To overcome this limitation, we developed a computationally guided method to design inactive proenzymes or zymogens, which are activated through cleavage by a protease. Since proteases are differentially expressed in various tissues and disease states, including cancer, these proenzymes could be targeted to the desired microenvironment. We tested our method on the therapeutically relevant protein carboxypeptidase G2 (CPG2). We designed Pro-CPG2s that are inhibited by 80 to 98% and are partially to fully reactivatable following protease treatment. The developed methodology, with further refinements, could pave the way for routinely designing protease-activated protein-based therapeutics and diagnostics that act in a spatially controlled manner.
All Related Versions
Funding Information
  • HHS | National Institutes of Health (GM132565)
  • National Science Foundation (MCB1716623)
  • Gouvernement du Canada | Canadian Institutes of Health Research (PostdocFellowship)
  • HHS | NIH | National Institute of General Medical Sciences (T32GM135141)

This publication has 51 references indexed in Scilit: